![]() |
RELATED RESOURCES |
SEC Filings:ANPCANPAC BIO-MEDICAL SCIENCE CO LTD0.3038
|
Year | Type ![]() |
![]() |
Period End Date | |
---|---|---|---|---|
2022 | Form 6-K | Foreign Issuer Current Report | 05/11/2022 | 05/11/2022 |
Form 6-K | Foreign Issuer Current Report | 05/09/2022 | 05/09/2022 | |
Form 6-K | Foreign Issuer Current Report | 05/06/2022 | 05/06/2022 | |
2021 | Form NT 20-F | Notice under Rule 12b25 | 05/02/2022 | 12/31/2021 |
2022 | Form 6-K | Foreign Issuer Current Report | 04/21/2022 | 04/21/2022 |
Form 6-K | Foreign Issuer Current Report | 04/11/2022 | 04/12/2022 | |
Form 6-K | Foreign Issuer Current Report | 03/28/2022 | 03/28/2022 | |
Form 6-K | Foreign Issuer Current Report | 03/11/2022 | 03/11/2022 | |
Form 6-K | Foreign Issuer Current Report | 02/15/2022 | 02/15/2022 | |
Form SC 13D/A | Acquistion of beneficial ownership | 02/14/2022 | N/A | |
Form 6-K | Foreign Issuer Current Report | 01/24/2022 | 01/24/2022 | |
2021 | Form 6-K | Foreign Issuer Current Report | 11/26/2021 | 11/26/2021 |
Form 6-K | Foreign Issuer Current Report | 11/15/2021 | 11/15/2021 | |
Form 424B5 | Prospectus | 11/12/2021 | N/A | |
Form 6-K | Foreign Issuer Current Report | 11/12/2021 | 11/12/2021 |